Chen, Y., Xie, Y., Sang, D., Xie, N., Han, X., Zhao, Y., . . . Wang, B. Real-world comparison of palbociclib, abemaciclib, and dalpiciclib as first-line treatments for Chinese HR+/HER2−metastatic breast cancer patients: A multicenter study (YOUNGBC-28). SAGE Publishing.
Chicago Style (17th ed.) CitationChen, Yifan, et al. Real-world Comparison of Palbociclib, Abemaciclib, and Dalpiciclib as First-line Treatments for Chinese HR+/HER2−metastatic Breast Cancer Patients: A Multicenter Study (YOUNGBC-28). SAGE Publishing.
MLA (9th ed.) CitationChen, Yifan, et al. Real-world Comparison of Palbociclib, Abemaciclib, and Dalpiciclib as First-line Treatments for Chinese HR+/HER2−metastatic Breast Cancer Patients: A Multicenter Study (YOUNGBC-28). SAGE Publishing.
Warning: These citations may not always be 100% accurate.